
Peak concentrations occurred approximately 1.5 hours after the dose.Īmoxicillin serum concentrations achieved with amoxicillin and clavulanate potassium are similar to those produced by the oral administration of equivalent doses of amoxicillin alone. Onabotulinumtoxin A, incobotulinumtoxin A, abobotulinumtoxin A, rimabotulinumtoxin B, prabotulinumtoxin AĮxcept when sold as brimonidine tartrate ophthalmic solution in concentrations up to and including 0.* Mean values of 14 normal volunteers (n = 15 for clavulanate potassium in the low-dose regimens). When sold or recommended for the treatment of homocystinuriaīishydroxycoumarin or its salts or derivatives In concentrations greater than 5% or when sold in combination with another medicinal ingredient When sold for administration by injectionĪzilsartan medoxomil or its salts or derivatives When sold in topical formulations containing alpha-hydroxy acids alone or in combination at concentrations greater than 30% and/or with a pH lower than 3.0, except when sold to be applied to warts, corns or calluses.Īminolevulinic acid or its salts or derivativesĪmphotericin B or its salts or derivatives Fluticasone propionate for the treatment of allergic rhinitis in a nasal spray that delivers 50 microgram/spray for those 18 years of age and older.Ĭitric acid, glycolic acid, lactic acid, malic acid, mandelic acid, ammonium glycolate, glycolic acid + ammonium glycolate, alpha-hydroxyethanoic acid + ammonium alpha-hydroxyethanoate, alpha-hydroxyoctanoic acid, alpha-hydroxycaprylic acid, hydroxycaprylic acid, mixed fruit acid, triple fruit acid, tri-alpha-hydroxy fruit acids, alpha-hydroxy and botanical complex, l-alpha-hydroxy acid, glycomer in cross-linked fatty acids alpha nutrium Mometasone furoate for the treatment of allergic rhinitis in a nasal spray that delivers 50 microgram/spray for those 12 years of age and older.į. triamcinolone acetonide in a nasal spray that delivers 55 microgram/spray for those 12 years of age and older or,Į.
#Pill look up 22 75 skin
clobetasone butyrate when sold in a concentration of 0.05% in cream preparations for topical use on the skin or,ĭ. hydrocortisone or hydrocortisone acetate, when sold in combination with any other nonprescription medicinal ingredient that provides 1.0% or less hydrocortisone in preparations for topical use on the skin or,Ĭ. hydrocortisone or hydrocortisone acetate, when sold as a single medicinal ingredient in a concentration that provides 1.0% or less hydrocortisone in preparations for topical use on the skin or,ī. When sold or recommended for administration by intravenous injectionĪdrenocortical hormones or their salts or derivativesĪ.

When recommended for administration by intravenous injection When sold or recommended as anticoagulants Products for Human Use Drugs containing any of the followingĢ,4-Dinitrophenol or its salts or derivativesĤ-Amino-pteroyl aspartic acid or its salts

(Does not include medicinal ingredients listed in the Controlled Drugs and Substances Act Schedules)
